UK markets close in 2 hours 28 minutes

Lupin Limited (LUPIN.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,645.45+7.90 (+0.48%)
At close: 03:29PM IST

Lupin Limited

Kalpataru Inspire
3rd Floor Off. Western Expressway Highway Santacruz (East)
Mumbai 400055
India
91 22 6640 2323
https://www.lupin.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees20,933

Key executives

NameTitlePayExercisedYear born
Ms. Vinita D. GuptaCEO & Executive Director109.2MN/A1968
Mr. Ramesh SwaminathanGlobal CFO, CRO, Head of Corporate Affairs & Executive Director66.86MN/A1966
Mr. Nilesh Deshbandhu GuptaMD & Executive Director49.6MN/AN/A
Mr. Johnny Mack MikellPresident & Global Head of QualityN/AN/AN/A
Mr. Christoph FunkeChief Technical Operations OfficerN/AN/AN/A
Mr. Sreeji GopinathanChief Information OfficerN/AN/AN/A
Dr. Shahin FesharakiGlobal Chief Scientific OfficerN/AN/AN/A
Dr. Hemant BakhruVice President of Investor Relations and M&AN/AN/AN/A
Dr. Sofia MumtazPresident of Legal and Compliance of Australia, Japan & Canada BusinessN/AN/AN/A
Ms. Diana Amador-ToroSenior Vice President of Global ComplianceN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilars; over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Corporate governance

Lupin Limited’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 10; Board: 4; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.